Brian Aevermann
Brian Aevermann
Thanks Batu! I will take a look! On Mon, Jun 27, 2022 at 6:37 PM Batuhan Cakir ***@***.***> wrote: > Hello everyone, > > We created a guide with an...
I think most of these tasks have been handled. The developer version has not been officially formulated yet, but I think that is in the offing. Can I close ticket?
see: http://bioportal.bioontology.org/ontologies/HP/?p=classes&conceptid=http%3A%2F%2Fpurl.obolibrary.org%2Fobo%2FHP_0032443
We will discuss during our January call. And also these changes will need to be discussed in the manuscript.
Not going to add class. But: Disease specific -> paper? Describing how to model/represent using OGMS and how to create user/disease specific stages Staging -> information content entity...
Parts 2 & 3 of the definition may be too expansive. Possibly reduce to part 1 only?
A prophylactic treatment that has as occurrent part some administering of a drug product that either (1) contains some hormone as active ingredient, (2) regulates the production of some hormone,...
Currently fixing IRIs and this came to my attention. Should I use the OBI IRI or would that cause an up stream collision in OBO, etc?
Could be diagnosing disease stage/course and not just the specific histological stage (as in stage IIIa). Subclass of diagnostic process ... add in notion of comparing signs and symptoms to...
The definition needs to be expanded as the use case for the term, which was being discussed, can be applied to not only a disease but also a disease stage...